Literature DB >> 16960115

Cattle husbandry in Ethiopia is a predominant factor affecting the pathology of bovine tuberculosis and gamma interferon responses to mycobacterial antigens.

Gobena Ameni1, Abraham Aseffa, Howard Engers, Douglas Young, Glyn Hewinson, Martin Vordermeier.   

Abstract

Bovine tuberculosis is a major economic problem and a potential public health risk. Improved diagnostics like the gamma interferon (IFN-gamma) test with ESAT6 and/or CFP10 could contribute to the control program. We assessed IFN-gamma responses in zebu (Ethiopian Arsi breed) and Holstein cattle kept indoors or in a pasture to tuberculin purified protein derivative (PPD) and an ESAT6-CFP10 protein cocktail. Furthermore, the intensity and distribution of pathology of bovine tuberculosis were compared between the two breeds. Our data demonstrated significantly (all P < 0.02) higher IFN-gamma responses to avian PPD, bovine PPD, and the ESAT6-CFP10 protein cocktail in Holstein than in zebu cattle, while lesion severities in infected animals and tuberculin skin test responses did not differ significantly (P > 0.05) between the two breeds. Holstein cattle that were kept indoors produced significantly (all P < 0.01) higher IFN-gamma levels in response to avian PPD, bovine PPD, and the ESAT6-CFP10 protein cocktail than did Holstein cattle kept in a pasture. Moreover, lesion severity was significantly higher in Holstein cattle kept indoors (P = 0.001) than in those kept in the pasture. Lesions were localized predominantly in the digestive tract in cattle kept in a pasture, while they were localized in the respiratory tract in cattle kept indoors. In conclusion, in Holstein cattle, husbandry was a dominant factor influencing the severity of tuberculosis lesions and IFN-gamma responses to mycobacterial antigens compared to breed. A difference in the cellular immune response between zebu and Holstein cattle was observed, while tuberculosis lesion severities were identical in the two breeds, when both were kept in a pasture.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16960115      PMCID: PMC1563579          DOI: 10.1128/CVI.00134-06

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  29 in total

Review 1.  Epidemiology of selected mycobacteria that infect humans and other animals.

Authors:  D A Ashford; E Whitney; P Raghunathan; O Cosivi
Journal:  Rev Sci Tech       Date:  2001-04       Impact factor: 1.181

2.  Comparison between comparative tuberculin and gamma-interferon tests for the diagnosis of bovine tuberculosis in Ethiopia.

Authors:  G Ameni; H Miörner; F Roger; M Tibbo
Journal:  Trop Anim Health Prod       Date:  2000-10       Impact factor: 1.559

3.  Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle.

Authors:  H M Vordermeier; A Whelan; P J Cockle; L Farrant; N Palmer; R G Hewinson
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

4.  Kinetics of interferon-gamma (IFN-gamma) release in the peripheral blood of calves vaccinated with BCG.

Authors:  G Ameni; M Tibbo
Journal:  J Immunoassay Immunochem       Date:  2002

5.  Identification of novel Mycobacterium tuberculosis antigens with potential as diagnostic reagents or subunit vaccine candidates by comparative genomics.

Authors:  P J Cockle; S V Gordon; A Lalvani; B M Buddle; R G Hewinson; H M Vordermeier
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  IL-10-producing T cells suppress immune responses in anergic tuberculosis patients.

Authors:  V A Boussiotis; E Y Tsai; E J Yunis; S Thim; J C Delgado; C C Dascher; A Berezovskaya; D Rousset; J M Reynes; A E Goldfeld
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

7.  Lymphocyte subtypes in experimentally induced early-stage bovine tuberculous lesions.

Authors:  J P Cassidy; D G Bryson; M M Gutiérrez Cancela; F Forster; J M Pollock; S D Neill
Journal:  J Comp Pathol       Date:  2001-01       Impact factor: 1.311

8.  Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis.

Authors:  H Martin Vordermeier; Mark A Chambers; Paul J Cockle; Adam O Whelan; Jennifer Simmons; R Glyn Hewinson
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

9.  Influence of disease severity on nitrite and cytokine production by peripheral blood mononuclear cells (PBMC) from patients with pulmonary tuberculosis (TB).

Authors:  D Dlugovitzky; M L Bay; L Rateni; G Fiorenza; L Vietti; M A Farroni; O A Bottasso
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

10.  Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination.

Authors:  B M Buddle; D N Wedlock; N A Parlane; L A L Corner; G W De Lisle; M A Skinner
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

View more
  38 in total

1.  Prevalence and risk factors of mycobacterial infections in farm and trade cattle in southwestern Nigeria.

Authors:  Victor O Akinseye; Muideen D Adebayo; Oghenekaro O Genesis; Olubukola D Adelakun; Simeon I B Cadmus
Journal:  Trop Anim Health Prod       Date:  2017-12-22       Impact factor: 1.559

Review 2.  Bovine tuberculosis in Ethiopia: A systematic review and meta-analysis.

Authors:  Berhanu Sibhat; Kassahun Asmare; Kassa Demissie; Gelagay Ayelet; Gezahegne Mamo; Gobena Ameni
Journal:  Prev Vet Med       Date:  2017-09-18       Impact factor: 2.670

3.  Risk factors associated with prevalence of tuberculosis-like lesions and associated mycobacteria in cattle slaughtered at public and export abattoirs in Ethiopia.

Authors:  Demelash Biffa; Francis Inangolet; Asseged Bogale; James Oloya; Berit Djønne; Eystein Skjerve
Journal:  Trop Anim Health Prod       Date:  2010-11-18       Impact factor: 1.559

4.  A cross-sectional study on bovine tuberculosis in Hawassa town and its surroundings, Southern Ethiopia.

Authors:  Alemayehu Regassa; Asmelash Tassew; Kebede Amenu; Bekele Megersa; Fufa Abunna; Berhanu Mekibib; Tanguy Marcotty; Tanguy Macrotty; Gobena Ameni
Journal:  Trop Anim Health Prod       Date:  2009-12-03       Impact factor: 1.559

5.  Cellular and Cytokine Responses in the Granulomas of Asymptomatic Cattle Naturally Infected with Mycobacterium bovis in Ethiopia.

Authors:  Begna Tulu; Henny M Martineau; Aboma Zewude; Fekadu Desta; David A Jolliffe; Markos Abebe; Taye Tolera Balcha; Mulugeta Belay; Adrian R Martineau; Gobena Ameni
Journal:  Infect Immun       Date:  2020-11-16       Impact factor: 3.441

6.  Prevalence of bovine tuberculosis in Ethiopian slaughter cattle based on post-mortem examination.

Authors:  B Demelash; F Inangolet; J Oloya; B Asseged; M Badaso; A Yilkal; E Skjerve
Journal:  Trop Anim Health Prod       Date:  2008-12-05       Impact factor: 1.559

7.  Comparison of different testing schemes to increase the detection Mycobacterium bovis infection in Ethiopian cattle.

Authors:  Gobena Ameni; Abraham Aseffa; Glyn Hewinson; Martin Vordermeier
Journal:  Trop Anim Health Prod       Date:  2009-09-13       Impact factor: 1.559

8.  Appraisal of interpretation criteria for the comparative intradermal tuberculin test for diagnosis of tuberculosis in cattle in central Ethiopia.

Authors:  Gobena Ameni; Glyn Hewinson; Abraham Aseffa; Douglas Young; Martin Vordermeier
Journal:  Clin Vaccine Immunol       Date:  2008-05-21

9.  Bovine tuberculosis: prevalence and diagnostic efficacy of routine meat inspection procedure in Woldiya municipality abattoir north Wollo zone, Ethiopia.

Authors:  Alemu Aylate; Shahid Nazir Shah; Haileluel Aleme; Tarkegn Tintagu Gizaw
Journal:  Trop Anim Health Prod       Date:  2012-10-20       Impact factor: 1.559

Review 10.  Classification of worldwide bovine tuberculosis risk factors in cattle: a stratified approach.

Authors:  Marie-France Humblet; Maria Laura Boschiroli; Claude Saegerman
Journal:  Vet Res       Date:  2009-06-06       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.